文献速递关节外科

局部氨甲环酸在翻修全膝关节置换术中降低输血率并可能与早期恢复相关

Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated With Earlier Recovery.
PubMed 文献 · J Arthroplasty · 2018-10-25

该回顾性研究比较76例接受局部TXA(3 g,止血带放气前)的翻修TKA患者与205例未使用TXA的历史对照组。结果显示,研究组估计失血量、血红蛋白下降幅度和输血率显著低于对照组,6周时膝关节协会评分改善显著更高,两组血栓栓塞并发症无显著差异。

要点

  • 局部TXA(3 g,止血带放气前)可显著降低翻修TKA的估计失血量、血红蛋白下降和输血率。
  • 术后6周膝关节协会评分改善研究组显著高于对照组,血栓栓塞并发症两组无显著差异。

核心结论

  • 局部TXA在翻修TKA中安全有效,可减少失血和输血,当股骨和胫骨组件均翻修时效果更明显,且可能改善早期结果。

研究设计与样本

  • 回顾性比较76例接受局部TXA(止血带放气前3 g)的翻修TKA患者(研究组)与205例未使用TXA的历史对照组,按翻修类型分层,随访至少6周。

主要发现

  • 研究组平均估计失血量、血红蛋白下降和输血率均显著低于对照组(P=0.008、P<0.001、P<0.001)。
  • 两组隐性失血量相似(P=0.12)。
  • 术后6周,研究组膝关节协会评分改善显著高于对照组(P<0.001)。
  • 两组血栓栓塞并发症无显著差异(P=0.92)。

关键数值与推荐

  • 局部TXA用法为止血带放气前给予3 g。
  • 估计失血量组间比较P=0.008,血红蛋白下降P<0.001,输血率P<0.001,隐性失血P=0.12,血栓栓塞并发症P=0.92,膝关节协会评分改善P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of tranexamic acid (TXA) has been proved to be effective in reducing blood loss and transfusion requirements after primary total knee arthroplasty (TKA). However, the evidence for its use in revision surgery is scant. We assessed the safety and efficacy of topical TXA in revision TKA. METHODS: We retrospectively compared 76 revision TKA patients who received topical TXA (3 g before tourniquet deflation) "study group" with a historic control group of 205 revision TKA patients in which TXA was not used. Each group was further stratified into subgroups according to the type of revision. All patients were followed for a minimum of 6 weeks. Blood loss, transfusion requirements, changes in hemoglobin-hematocrit levels, Knee Society Score, and complications were recorded. RESULTS: The mean estimated blood loss, hemoglobin drop, and transfusion rate were significantly lower in the study group than in the control group (P = .008, P < .001, P < .001, respectively). Hidden blood loss was similar between the 2 groups (P = .12). Six weeks postoperatively, the improvement in the knee-specific Knee Society Score was significantly higher in the study group than in the control group (P < .001). No significant differences were found in thromboembolic complications between the 2 groups (P = .92). In the subgroup analysis, when both components (femur and tibia) were revised, the relative risk of transfusion was significantly lower with the use of TXA (relative risk 0.227, confidence interval 0.0593-0.860, P = .004). CONCLUSION: Topical TXA in revision TKA is safe and effective in reducing blood loss and transfusions. This effect is enhanced when both components are revised. Additionally, the use of TXA may improve early outcomes.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Huerfano E, Huerfano M, Shanaghan KA, et al. Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated With Earlier Recovery. J Arthroplasty. 2018. PMID: 30448325. doi:10.1016/j.arth.2018.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。